Product Name: (1R,2R)-(-)-1,2-Cyclohexanedicarboxylic acid CAS 46022-05-3
Chemical & Physical Properties
Appearance : off-white or white powder
Boiling Point: 384.1℃ at 760 mmHg
(1R,2R)-Cyclohexane-1,2-dicarboxylic acid is the key intermediate of lulasidone hydrochloride, which is a new atypical antipsychotic developed by Sumitomo pharmaceutical company of Japan. It was first marketed in the United States in 2010, and was approved by FDA for the treatment of adult schizophrenia and as a monotherapy / adjuvant therapy of lithium salt or valproic acid for the suppression of bipolar I disorder in adult patients Depression attack.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.